<p><a target="_blank" href="https://ascopubs.org/doi/10.1200/JCO.2010.28.7078">Reduced Melanoma After Regular Sunscreen Use: Randomized Trial Follow-Up</a></p><p><a target="_blank" href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2848408">GLP-1 Receptor Agonists or SGLT2 Inhibitors and Nonarteritic Anterior Ischemic Optic Neuropathy</a></p><p>* Previously discussed on Fornight XXII: <a target="_blank" href="https://www.bmj.com/content/392/bmj-2025-086886">Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study</a></p> <br/><br/>This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.sensible-med.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.sensible-med.com/subscribe</a>